ZNF16 and gallbladder carcinoma: Especially, MYC and the Wnt/β-catenin pathway might be a potential therapeutic targets of gallbladder carcinomas with high expression of FAM83H/ZNF16 because MYC is a transcriptional regulator of FAM83H and FAM83H stabilizes β-catenin [5, 6, 28, 29].